DHL to ship Covid-19 vaccines weekly to Australia and New Zealand

  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share on Pinterest
  • Share on Blogger

To support the Australian and New Zealand government’s inoculation programme, DHL Global Forwarding, the air and ocean freight specialist of Deutsche Post DHL Group, will deliver additional doses of Covid-19 vaccines on a weekly basis into the countries. DHL Global Forwarding arranged for the collection and airfreight of the vaccines from the manufacturing site in Europe and upon the vaccines’ arrival in Australia and the Auckland Airport, handled the customs clearance and final delivery to the designated locations.

“Logistics plays a critical role in getting vaccines to where it is urgently needed. Globally, across many markets, our cold-chain network and pharmaceutical logistics expertise have meticulously planned every last detail to manage an extremely complex operation seamlessly,” said Charles Kaufmann, CEO, DHL Global Forwarding North Asia & South Pacific.

The strength of DHL’s global logistics network is deployed in Australia’s on-going response to the Covid-19. In December last year, the Australian Department of Health announced contracts with logistics partners, including DHL Supply Chain, to “design and operate a national distribution network” to support nationwide vaccinations even in remote and hard to reach areas.

“The shipments were delivered on time, and most importantly, in the right condition according to strict requirements. That’s the result of many months of rigorous planning to ensure the vaccines are delivered within the fastest possible time while ensuring the quality, safety and security of these critical shipments,” said George Lawson, managing director, DHL Global Forwarding Australia.

“Connecting People, Improving Lives is part of our Group’s core purpose. As we join the global response to the pandemic, we live this by doing what we do best – providing first rate logistics in the communities we operate in,” Lawson added.

“The deliveries were smooth as can be expected, thanks to the significant effort and rigorous planning by the teams involved. Working in close coordination with our partners on the ground and New Zealand’s regulatory authorities, all measures have been taken to ensure not just the speed of deliveries, but also ensuring the quality and safety of these critical shipments,” said Zane Morton, managing director, DHL Global Forwarding New Zealand.

Across DHL’s dedicated global network, more than 9,000 specialists work to connect pharmaceutical and research organisations, wholesalers and distributors, as well as hospitals and healthcare providers across the value chain. With this contract, the logistics expert for air, ocean and road freight expands its global presence in vaccine distribution.

DHL’s portfolio for the healthcare industry includes over 150 pharmacists, 20 clinical trials depots, 100 certified stations, 160 GDP-qualified warehouses, 15 GMP-certified sites, 135 medical express sites, and an international network covering 220 countries and territories.

On a global scale, logistics providers are challenged to establish medical supply chains rapidly to deliver vaccines of unprecedented amount of more than 10 billion doses worldwide – also in regions with less developed logistics infrastructure, where approximately 3 billion people live. To provide global coverage of the next two years, DHL estimated in its vaccine whitepaper report that up to 200,000 pallet shippers and 15 million cooling boxes as well as 15,000 flights will be required across the various supply chain setups.

  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share on Pinterest
  • Share on Blogger